ClinicalTrials.gg
Sign In

Glomerulonephritis clinical trials

The registry lists 115 studies for Glomerulonephritis across more than 10 countries. 32 are recruiting or about to start. 40 of them are mainly about Glomerulonephritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 5 narrower conditions too, such as Lupus Nephritis: 895 studies, 330 open.

Get an email when these change. Save the Glomerulonephritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
49
Recruiting
25
Status unknown
16
Terminated
11
Not yet recruiting
6
Active, not recruiting
6

Phase

Phase 2
39
Phase 4
19
Phase 3
19
Phase 1
12

Where

United States
40
China
24
United Kingdom
21
Taiwan
15
Australia
14
Spain
14

Who runs them

Novartis Pharmaceuticals (7) · Assiut University (5) · Chinese University of Hong Kong (5) · Mayo Clinic (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Goldfinch Bio, Inc. (3) · Istanbul University (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3)

What is being tested here

Drugs under test in Glomerulonephritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dapagliflozin202
JADE101212
Atrasentan123
Zigakibart122
Iptacopan112
Mycophenolic Acid102
Dexamethasone112
TACI receptor-IgG Fc fragment fusion protein102
Hydroxychloroquine102
Vensobafusp alfa101

Drug classes tested here Endothelin receptor antagonists 2 open · Corticosteroids 2 open · SGLT2 inhibitors 2 open · Angiotensin receptor blockers (ARBs) 1 open

Coming up

9phase 3 studies under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 25 Glomerulonephritis studies recruiting now, 14 (56%) set no upper age limit and 6 (24%) stop at 75 or younger. 6 (24%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (8%) take healthy volunteers.

Recruiting studies that take each age, of 25
AgeWomenMen
105 (20%)5 (20%)
1823 (92%)23 (92%)
3023 (92%)23 (92%)
4023 (92%)23 (92%)
5023 (92%)23 (92%)
6522 (88%)22 (88%)
7520 (80%)20 (80%)
8516 (64%)16 (64%)

Across all 115 studies, recruiting or not: 34% stop at 75 or younger and 19% at 65; 23% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting3

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 115. Browse all 115 → or search them.